Summit Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.63M | Sell |
8,810
-1,786
| -17% | -$938K | 0.1% | 169 |
|
|
2025
Q1 | $6.72M | Buy |
10,596
+64
| +0.6% | +$40.6K | 0.19% | 106 |
|
|
2024
Q4 | $7.5M | Sell |
10,532
-2,250
| -18% | -$1.6M | 0.26% | 70 |
|
|
2024
Q3 | $13.4M | Buy |
12,782
+4,608
| +56% | +$4.84M | 0.53% | 32 |
|
|
2024
Q2 | $8.59M | Buy |
8,174
+883
| +12% | +$928K | 0.39% | 43 |
|
|
2024
Q1 | $7.02M | Sell |
7,291
-717
| -9% | -$690K | 0.42% | 31 |
|
|
2023
Q4 | $7.03M | Buy |
8,008
+1,650
| +26% | +$1.45M | 0.46% | 29 |
|
|
2023
Q3 | $5.23M | Sell |
6,358
-482
| -7% | -$397K | 0.39% | 37 |
|
|
2023
Q2 | $4.91M | Buy |
+6,840
| New | +$4.91M | 0.36% | 39 |
|